cycloserine has been researched along with cefoxitin in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antignac, A; Tomasz, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brozovic, A; Dowson, CG; Gazvoda, M; KoĊĦmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
| Bartlett, JG; Willey, SH | 1 |
| Bettin, KM; Clabots, CR; Gerding, DN; Peterson, LR | 1 |
| Levett, PN | 1 |
| Armitt, I; Herriot, A; Thakker, B; Thirkell, D | 1 |
| Bowman, RA; Carroll, SM; Riley, TV | 1 |
| Fedorko, DP; Williams, EC | 1 |
| Bliss, DZ; Clabots, CR; Gerding, DN; Johnson, S; Savik, K | 1 |
| Boseiwaqa, LV; Carson, KC; Foster, NF; Riley, TV; Thean, SK | 1 |
| Citron, DM; Goldstein, EJ; Leoncio, ES; Merriam, CV; Tyrrell, KL | 1 |
| Boseiwaqa, LV; Carson, KC; Foster, NF; Riley, TV; Squire, MM; Thean, SK | 1 |
| Banevicius, MA; Housman, ST; Lamb, LM; Nicolau, DP | 1 |
1 review(s) available for cycloserine and cefoxitin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 other study(ies) available for cycloserine and cefoxitin
| Article | Year |
|---|---|
Reconstruction of the phenotypes of methicillin-resistant Staphylococcus aureus by replacement of the staphylococcal cassette chromosome mec with a plasmid-borne copy of Staphylococcus sciuri pbpD gene.
Topics: Blotting, Northern; Blotting, Western; Chromatography, High Pressure Liquid; Chromosomes, Bacterial; Electrophoresis, Polyacrylamide Gel; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Penicillin-Binding Proteins; Peptidoglycan; Phenotype; Plasmids; RNA, Bacterial; Staphylococcus; Transduction, Genetic | 2009 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Cultures for Clostridium difficile in stools containing a cytotoxin neutralized by Clostridium sordellii antitoxin.
Topics: Antitoxins; Bacterial Toxins; Cefoxitin; Clostridium; Culture Media; Cycloserine; Ethanol; Feces; Humans | 1979 |
Evaluation of cycloserine-cefoxitin-fructose agar and cycloserine-cefoxitin-fructose broth for recovery of Clostridium difficile from environmental sites.
Topics: Agar; Bacteriological Techniques; Cefoxitin; Clostridioides difficile; Culture Media; Cycloserine; Environmental Microbiology; Fructose; Hospitals | 1991 |
Effect of antibiotic concentration in a selective medium on the isolation of Clostridium difficile from faecal specimens.
Topics: Cefoxitin; Clostridium; Culture Media; Cycloserine; Feces; Humans | 1985 |
A screen for Clostridium difficile in the vagina: an out-patient study using and comparing selective media.
Topics: Carrier State; Cefoxitin; Clostridium; Clostridium Infections; Cresols; Culture Media; Cycloserine; Female; Fructose; Humans; Pregnancy; Pregnancy Complications, Infectious; Scotland; Vagina | 1984 |
A selective broth for Clostridium difficile.
Topics: Cefoxitin; Chromatography, Gas; Clostridium; Culture Media; Cycloserine; Cytotoxins; Feces; Gentamicins; Humans | 1983 |
Use of cycloserine-cefoxitin-fructose agar and L-proline-aminopeptidase (PRO Discs) in the rapid identification of Clostridium difficile.
Topics: Agar; Aminopeptidases; Bacterial Typing Techniques; Cefoxitin; Clostridioides difficile; Cycloserine; Fructose | 1997 |
Comparison of cycloserine-cefoxitin-fructose agar (CCFA) and taurocholate-CCFA for recovery of Clostridium difficile during surveillance of hospitalized patients.
Topics: Antibiotics, Antitubercular; Cefoxitin; Cephamycins; Cholagogues and Choleretics; Clostridioides difficile; Cross Infection; Culture Media; Cycloserine; Diarrhea; Feces; Fructose; Humans; Prospective Studies; Rectum; Surgical Stomas; Taurocholic Acid | 1997 |
Isolation of Clostridium difficile from faecal specimens--a comparison of chromID C. difficile agar and cycloserine-cefoxitin-fructose agar.
Topics: Agar; Alcohols; Bacteriological Techniques; Cefoxitin; Clostridioides difficile; Culture Media; Cycloserine; Feces; Fructose; Humans; Reproducibility of Results; Ribotyping; Sensitivity and Specificity; Stress, Physiological; Taurocholic Acid | 2013 |
Evaluation of cycloserine-cefoxitin fructose agar (CCFA), CCFA with horse blood and taurocholate, and cycloserine-cefoxitin mannitol broth with taurocholate and lysozyme for recovery of Clostridium difficile isolates from fecal samples.
Topics: Agar; Animals; Anti-Infective Agents; Cefoxitin; Clostridioides difficile; Clostridium Infections; Culture Media; Cycloserine; Erythrocytes; Feces; Fructose; Horses; Humans; Mannitol; Muramidase; Taurocholic Acid | 2013 |
Comparison of ChromID C. difficile agar and cycloserine-cefoxitin-fructose agar for the recovery of Clostridium difficile.
Topics: Agar; Cefoxitin; Clostridioides difficile; Cycloserine; Enterocolitis, Pseudomembranous; Ethanol; Fructose; Humans; Microbiological Techniques; Ribotyping; Temperature; Time Factors | 2013 |
Isolation and quantitation of Clostridium difficile in aqueous and fecal matter using two types of selective media.
Topics: Bacteriological Techniques; Cefoxitin; Chromogenic Compounds; Clostridioides difficile; Culture Media; Cycloserine; Enterocolitis, Pseudomembranous; Feces; Fructose; Humans | 2016 |